Company

Prism Pharmaceuticals Inc.

Prism Pharmaceuticals develops treatments for arrhythmias.

About

Prism Pharmaceuticals develops treatments for arrhythmias. The company is based in King of Prussia, US, and was acquired by E.W. Healthcare Partners in a USD 170.00 mn trade sale.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in